Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02812160 · ClinicalTrials.gov registry record · NA

Spatz Adjustable Balloon for Obesity (SABO)

A NA study of Obesity, sponsored by Spatz FGIA.

Completed
Registry status
NA
Development phase
288
Enrollment target
7
Study locations

NCT02812160: Completed NA study of Obesity, sponsored by Spatz FGIA.

NCT02812160 is a NA study of Obesity that has completed, run by Spatz FGIA. The registered enrollment target is 288 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (65% lower). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02812160, a NA study of Obesity, has completed, sponsored by Spatz FGIA.

COMPLETED
Registry status
NA
Development phase
288 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to determine whether the Spatz3 Adjustable balloon, a non-surgical device, is effective in the treatment of obesity.

Conditions Studied

Interventions

  • DEVICE Spatz3 Adjustable Balloon

Study Locations (7)

Illinois

  • University of Chicago - Chicago

Louisiana

  • Surgical Specialists of Louisiana - Metairie

Maryland

  • Endoscopic MicroSurgery Associates - Towson

Massachusetts

  • Brigham and Womans Hospital - Boston

Minnesota

  • Mayo Clinic - Rochester

New York

  • NY Manhattan VA Hospital - New York

Ohio

  • Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 288 participants
Start Date 2016-09-12
Est. Completion 2019-01
Phase NA

Sponsor

Spatz FGIA

2 total trials

What the Registry Record Tells You About NCT02812160

The ClinicalTrials.gov registry entry for NCT02812160 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (65% lower). The listed sponsor is Spatz FGIA, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Spatz3 Adjustable Balloon is the first listed.

NCT02812160 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Illinois, Louisiana, Maryland.

Frequently Asked Questions

What is clinical trial NCT02812160 about?

NCT02812160 is a clinical study titled "Spatz Adjustable Balloon for Obesity (SABO)". The purpose of this study is to determine whether the Spatz3 Adjustable balloon, a non-surgical device, is effective in the treatment of obesity.

What is the current status of trial NCT02812160?

This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2016-09-12. Estimated completion is 2019-01.

What conditions does trial NCT02812160 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02812160?

The interventions under investigation include: Spatz3 Adjustable Balloon (DEVICE).

Who is sponsoring clinical trial NCT02812160?

This trial is sponsored by Spatz FGIA, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02812160 being conducted?

This trial has 7 study locations across Illinois, Louisiana, Maryland, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.